[Form 4] Upstart Holdings, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Upstart Holdings insider Scott Darling executed an option exercise and contemporaneous sale under a Rule 10b5-1 plan on 09/17/2025. The filing shows exercise of an employee stock option to acquire 1,000 shares at an exercise price of $13.22 per share, and the sale of 1,000 shares at a weighted average price of $70.0095 per share. After these transactions the reporting person beneficially owned 123,898 shares of common stock. The filing also discloses employee stock options covering a total of 199,527 underlying shares, and that certain shares counted in holdings are restricted stock units subject to vesting.
Positive
- Transaction executed pursuant to a Rule 10b5-1 trading plan, indicating pre-arranged execution
- Significant retained holdings: 123,898 shares beneficially owned after the transactions
- Substantial option exposure remains: options covering 199,527 underlying shares
Negative
- Insider sold 1,000 shares at a weighted average price of $70.0095, reducing common stock holdings from 124,898 to 123,898
- Some holdings are restricted stock units (RSUs) and remain subject to vesting conditions
Insights
TL;DR: Routine insider exercise and sale under a 10b5-1 plan; holdings remain material.
The Form 4 documents a planned exercise of an employee option and an immediate sale of the same number of shares under a Rule 10b5-1 trading plan adopted May 30, 2025. The exercise price was $13.22 and the sale realized a weighted average of $70.0095, representing a material per-share gain relative to exercise price. Post-transaction beneficial ownership remains significant at 123,898 shares, plus options covering 199,527 underlying shares and RSUs subject to vesting. This is a transactional disclosure rather than a signal of changed control or corporate action.
TL;DR: Properly documented 10b5-1 execution; no governance red flags in the filing itself.
The filing states the trades were effected pursuant to a Rule 10b5-1 plan adopted May 30, 2025 and includes the required explanations and signature via power of attorney. The disclosure identifies the reporting person as Chief Legal Officer and provides clear post-transaction holdings and option schedules. There are no indications in this Form 4 of accelerated vesting, related-party transactions, or deviations from standard insider-plan execution.